Since 2003, I have been a consultant for biotechnology and pharmaceutical companies as well as for academic research groups and institutes...

Project evaluations, feasability studies involving in silico approaches or combining experimental and in silico approaches (structural bioinformatics, chemoinformatics...).

Topics include:

  • Structural analysis of potential protein targets, peptides, binding pockets...hot spots, warm spots..
  • Compound collections
  • Early ADME-Tox
  • Virtual screening
  • Hit optimization
  • Intermolecular interactions
  • Protein-protein & protein-peptides interactions
  • Protein-mAb interactions
  • Protein stabilization
  • Homology modeling
  • Docking (macromolecular, ligands, fragments...)
  • Data mining
  • Drug repositioning
  • Analysis of variants....

If you have questions please contact me by email

The Biopharmaceutics Drug Distribution and Classification System (BDDCS)
attempts to split compounds into four classes based on their permeability
and solubility properties. There are many applications of the BDDCS system
such as trying to predict drug-drug interactions, elimination routes,
central nervous system exposure, toxicity, and environmental impacts
of drugs to cite a few of them...About 900 annotated drugs are shown,
each class is shown in a different color and the markers have different shapes.



Analysis of point mutations in antithrombin
using residue interaction network and clustering.

The first mutation (left) is not damaging,
the second one is likely to be as confirmed


Compound clustering - heatmap color according to tanimoto matrix









  • Last updated on .




Follow me

© Bruno Villoutreix. A first version of this Website was launched in 2006. Thank to Natacha Oliveira